KENNETH CRUMP: Open Payments
NPI 1891719308 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 24 payments from 14 companies in 2025. Trend: 2023 $595 · 2024 $327 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Globus Medical, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $39 |
| Boston Scientific Corporation | 2 | $39 |
| bioMerieux Inc | 1 | $34 |
| Exact Sciences Corporation | 2 | $29 |
| Inspire Medical Systems, Inc. | 2 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Neuronetics, Inc. | 1 | $23 |
Products named: CAPLYTA, Senza, WaveWriter Alpha Prime 16, Sunosi, INSPIRE, XIFAXAN, NEUROSTAR TMS THERAPY SYSTEM, EVENITY.
Industry payments across UT — which companies pay providers there.
